RGIN — Regenicin Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Regenicin, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2018 September 30th	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K/A	10-K
Standards:	USG	USG	USG	—	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.003	0.001	0.001	0.002	0.015
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.056	0.005	0.004	0.005	0.015
Other Long Term Assets
Total Assets	0.056	0.005	0.004	0.005	0.015
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	3.06	3.73	4.29	4.96	5.61
Total Long Term Debt
Total Debt
Total Liabilities	3.06	3.73	4.29	4.96	5.61
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-3	-3.73	-4.29	-4.96	-5.6
Total Liabilities & Shareholders' Equity	0.056	0.005	0.004	0.005	0.015
Total Common Shares Outstanding
Total Preferred Shares Outstanding